Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
17196 | 549 | 42.4 | 72% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
851 | 11028 | KINDLING//ABSENCE EPILEPSY//EPILEPSY RESEARCH |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | EXPT NEUROCHEM | Address | 6 | 47% | 2% | 9 |
2 | DL HOMOCYSTEIC ACID INDUCED SEIZURES | Author keyword | 5 | 63% | 1% | 5 |
3 | ANTIEPILEPT OUTPATIENT CLIN | Address | 3 | 100% | 1% | 3 |
4 | ELTDK | Address | 3 | 100% | 1% | 3 |
5 | PESQUISA NEUROQUIM EXPT | Address | 3 | 45% | 1% | 5 |
6 | EXPT BIOL SCI | Address | 2 | 38% | 1% | 5 |
7 | CHEM BIOACT NAT SYNTHET PROD | Address | 2 | 67% | 0% | 2 |
8 | IRON INDUCED SEIZURES | Author keyword | 2 | 67% | 0% | 2 |
9 | TIP FAK BINASI | Address | 2 | 67% | 0% | 2 |
10 | NUCLEO TECNOL FARMACEUT | Address | 2 | 36% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SUPEROXIDE DISMUTASE LEVELS | 25 | 73% | 3% | 19 |
2 | LIPID PEROXIDATION LEVEL | 9 | 83% | 1% | 5 |
3 | INDUCED HIPPOCAMPAL DAMAGE | 7 | 46% | 2% | 11 |
4 | KAINATE INDUCED NEUROTOXICITY | 5 | 63% | 1% | 5 |
5 | HYPOXIA EXPOSED RATS | 3 | 60% | 1% | 3 |
6 | PILOCARPINE INDUCED SEIZURES | 3 | 11% | 4% | 24 |
7 | ARACHIDONIC ACID LEVEL | 2 | 67% | 0% | 2 |
8 | NITRITE FORMATION | 2 | 26% | 1% | 6 |
9 | THIOL REDOX STATE | 1 | 21% | 1% | 6 |
10 | FECL3 INJECTION | 1 | 100% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Role of oxidative stress in epileptic seizures | 2011 | 60 | 226 | 32% |
Effects of Antiepileptic Drugs on Antioxidant and Oxidant Molecular Pathways: Focus on Trace Elements | 2013 | 15 | 76 | 43% |
Seizures, antiepileptics, antioxidants and oxidative stress: an insight for researchers | 2008 | 41 | 75 | 67% |
Mitochondrial involvement and oxidative stress in temporal lobe epilepsy | 2013 | 20 | 101 | 28% |
Mitochondrial dysfunction in epilepsy | 2012 | 31 | 85 | 26% |
Mitochondria, oxidative stress, and temporal lobe epilepsy | 2010 | 91 | 311 | 16% |
Vitamin C: A new auxiliary treatment of epilepsy? | 2014 | 2 | 34 | 41% |
Mexidol: the spectrum of pharmacological effects | 2012 | 0 | 2 | 100% |
Effects of Valproate, Carbamazepine, and Levetiracetam on the Antioxidant and Oxidant Systems in Epileptic Patients and Their Clinical Importance | 2010 | 15 | 14 | 43% |
Oxidative stress parameters in different rat brain structures after electroconvulsive shock-induced seizures | 2008 | 10 | 22 | 68% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EXPT NEUROCHEM | 6 | 47% | 1.6% | 9 |
2 | ANTIEPILEPT OUTPATIENT CLIN | 3 | 100% | 0.5% | 3 |
3 | ELTDK | 3 | 100% | 0.5% | 3 |
4 | PESQUISA NEUROQUIM EXPT | 3 | 45% | 0.9% | 5 |
5 | EXPT BIOL SCI | 2 | 38% | 0.9% | 5 |
6 | CHEM BIOACT NAT SYNTHET PROD | 2 | 67% | 0.4% | 2 |
7 | TIP FAK BINASI | 2 | 67% | 0.4% | 2 |
8 | NUCLEO TECNOL FARMACEUT | 2 | 36% | 0.7% | 4 |
9 | BLOORVIEW EPILEPSY PROGRAMME | 1 | 40% | 0.4% | 2 |
10 | BIOASSAYS DRUG | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000177147 | COBALT EPILEPSY//COBALT INDUCED EPILEPSY//ISOLATED SPIKE |
2 | 0.0000140137 | POSTTRAUMATIC EPILEPSY//POST TRAUMATIC EPILEPSY//POST TRAUMATIC SEIZURES |
3 | 0.0000137674 | PILOCARPINE//STATUS EPILEPTICUS//MOSSY FIBER SPROUTING |
4 | 0.0000134648 | ALPHA TOCOPHEROL THERAPY//COMBINATION PATHOGENETIC THERAPY//GRP DEV MOL DIAGNOST IN IDUALIZED THER Y |
5 | 0.0000104833 | ABNORMAL PLASTICITY//EL MOUSE//EPILEPTIC MUTANT |
6 | 0.0000089781 | STAVANGER NEUROL UNIT//10 11 EPOXIDE//A1298C MUTATION |
7 | 0.0000086772 | BIOMOL INTERACT BREMEN//BIOL CHEM 2//YANGCHUN KU |
8 | 0.0000084338 | DIHYDROXYFUMARATE//LD 1227//MONDINO TOR VERGATA NEUROPHARMACOL |
9 | 0.0000074517 | NXY 059//INTRAUTERINE ISCHEMIA//ADV MAGNET ONANCE |
10 | 0.0000069225 | DELAYED CALCIUM DEREGULATION//RETINAL CELLS//APTRA |